Evidence map›Paper›PMID 30646538›Full record

ArticleInternational journal of molecular sciences2019

p21

Mee-Hyun Lee, Joydeb Kumar Kundu, Bu Young Choi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Mee-Hyun LeeChina-US (Henan) Hormel Cancer Institute, No.127, Dongming Road, Jinshui District, Zhengzhou 450008, China. mhyun_lee@hanmail.net.
Joydeb Kumar KunduLi Ka Shing Applied Virology Institute, University of Alberta, Edmonton, AB T6G 2R3, Canada. joydeb@ualberta.ca.
Bu Young ChoiDepartment of Pharmaceutical Science & Engineering, Seowon University, Cheongju 28674, Korea. bychoi2023@gmail.com.ORCID 0000-0001-8698-5880
China-US (Henan) Hormel Cancer Institute · CNSeowon University · KRUniversity of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hYSK1, a serine/threonine kinase (STK)-25, has been implicated in a variety of cellular functions including cell migration and polarity. We have recently reported that hYSK1 down-regulated the expression and functions of p16

Indexed as

Transcription, GeneticCell HypoxiaCell LineCell MovementCell PolarityCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Gene Expression RegulationHippo KinasesHumansIntracellular Signaling Peptides and ProteinsMatrix Metalloproteinase 2Membrane ProteinsPromoter Regions, GeneticProtein BindingProtein Interaction MapsACRV1 protein, humanCDKN1A protein, humanCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Cyclin-Dependent Kinase Inhibitor p21Hippo KinasesIntracellular Signaling Peptides and ProteinsMatrix Metalloproteinase 2Membrane ProteinsProtein Serine-Threonine KinasesSTK25 protein, humanhypoxiahYSK1MMP-2p21WAF1/Cip1tumor migration

Identifiers

PMID30646538
PMCPMC6359055
OpenAlexW2910198135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.